Xianlun Zhu

Dr. Xianlun Zhu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2012 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
XZXianlun Zhu
Xianlun Zhu
CRConcezio Di Rocco
Concezio Di Rocco

1 May 2018 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
DCDavid Yuen Chung Chan
David Yuen Chung Chan
TCTat Ming Danny TM Chan Chan
Tat Ming Danny TM Chan Chan
XZXianlun Zhu
Xianlun Zhu
PKPatricia Kwok Yee Kan
Patricia Kwok Yee Kan
ANAmelia Yikjin Ng
Amelia Yikjin Ng
GWGeorge Wong
George Wong

1 June 2016 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Open access
DCDavid Yuen Chung Chan
David Yuen Chung Chan
DCDanny Tat Ming Chan
Danny Tat Ming Chan
XZXianlun Zhu
Xianlun Zhu
CLClaire Ka Yee Lau
Claire Ka Yee Lau
HLHowan Leung
Howan Leung
WPWai Sang Poon
Wai Sang Poon

1 July 2022 in Surgical Neurology International
Verified
Journal Article
Open access
EFEva Lai-Wah Fung
Eva Lai-Wah Fung
CMChung-Yin Mo
Chung-Yin Mo
SFSharon Tsui-Hang Fung
Sharon Tsui-Hang Fung
ACAnne Yin-Yan Chan
Anne Yin-Yan Chan
KLKa-Yee Lau
Ka-Yee Lau
WPWai-Sang Poon
Wai-Sang Poon
Background: GNAO1 is an emerging disorder characterized with hypotonia, developmental delay, epilepsy, and movement disorder, which can be potentially life threatening during acute exacerbation. In the USA, deep brain stimulation (DBS) has been licensed for treating children with chronic, treatment-resistant primary dystonia, who are 7 years old or older. Case Description: A 4-year-old girl diagnosed to have GNAO1-related dyskinesia and severe global developmental delay. She had severe dyskinesia precipitated by intercurrent infection, requiring prolonged intensive care for heavy sedation and related complications. Her dyskinesia improved dramatically after DBS implantation. Technical difficulties and precautions of DBS in preschool children were discussed. Conclusion: DBS should be considered early in the treatment of drug-resistant movement disorders in young children with GNAO1, especially after dyskinetic crisis, as they tend to recur. Presurgical counseling to parents and close monitoring of complications is also important in the process.


10 May 2018 in Surgical Practice
Verified
Journal Article
Closed access
PDF file
DCDavid Yuen‐Chung Chan
David Yuen‐Chung Chan
XZXianlun Zhu
Xianlun Zhu
DCDanny Tat‐Ming Chan
Danny Tat‐Ming Chan
WPWai‐Sang Poon
Wai‐Sang Poon